Computational analyses using RNAinter have confirmed miR-145-5 p’s ability to target Homeobox A5 (HOXA5) (c = 0.1619), a transcription factor implicated in tamoxifen resistance and promotion of mesenchymal-like and stem cell properties in aggressive breast cancer phenotypes [22]. The gene discussed is HOXA5; the disease is breast carcinoma.